Pde5is

Abstract INTRODUCTION AND OBJECTIVES: Phosphodiesterase Type 5 (PDE5) inhibitor is effective in treating erectile dysfunction and is generally safe concerning cardiovascular (CV) risk profiles. We analyzed risk ratios and outcome of major adverse cardiovascular to depending on different period...

Erectile dysfunction is a common concern for prostate cancer patients, and PDE5 inhibitors (PDE5is) are a common treatment option. In this video from the ISSM and Movember, Dr. John Mulhall interviews Dr. Hossein Sadeghi-Nejad about how PDE5 inhibitors work, how to choose the right medication...

Objectives Phosphodiesterase 5 inhibitors (PDE5i) are considered among the first-line treatment options for erectile dysfunction (ED). Their impact in terms of long-term psychological well-being has been scantly analysed. This retrospective cross-sectional study aimed to investigate PDE5i...

Objectives Current data suggest that all available PDE5-inhibitors (PDE5is) appear equivalent for treating erectile dysfunction (ED). We aimed to compare the effectiveness of PDE5is in terms of a novel TRIFECTA outcome, including erectile function (EF), orgasmic function (OF), and psychological...

https://feeds.issuerdirect.com/news-release.html?newsid=6687692575178929 Internationally Published, Head-to-Head Data From India of Petros Pharmaceuticals' STENDRA(R) (Avanafil) Tablets Reported Improvement in Erectile Function Compared to Sildenafil and Baseline After 12 Weeks of Therapy Data...

A Review on Phosphodiesterase-5 Inhibitors as a Topical Therapy for Erectile Dysfunction (2022) Mohammadsadegh Hamzehnejadi, PharmD,Marziye Ranjbar Tavakoli, PharmD, Ardavan Abiri, PharmD, Ali Ghasempour, PharmD, Mohammad Amin Langarizadeh, PharmD, and Hamid Forootanfar, PhD ABSTRACT...